RCT on Telerehabilitation Efficacy in Parkinson's Disease (REPORT)
Parkinson Disease
About this trial
This is an interventional treatment trial for Parkinson Disease focused on measuring Telerehabilitation, Parkinson, Balance, Continuity of Care
Eligibility Criteria
Inclusion Criteria: Hoehn & Yahr (H&Y) score between ≤3 (ON-state); the absence of moderate and severe dyskinesias assessed by the MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) with a score of items 4.1 and 4.2 < 3; the absence of moderate and severe freezing episodes assessed by the MDS-UPDRS with a score of items 2.13 and 3.11 < 3; the ability to perform the 6 Minutes Walking Test (6MWT) between 200 m and 600 m; age ≤ 80 years; the absence of cognitive impairment measured by the Montreal Cognitive Assessment (MoCA) total score≥17.54 ; stabilized drug treatment; sufficient cognitive and linguistic level to understand and comply with study procedures; sign informed consent. Exclusion Criteria: other neurological pathologies, psychiatric complications, or personality disorders; blurred or low vision problems; hearing and speech impairment affecting participation in the study.
Sites / Locations
- IRCCS Bonino-Pulejo
- IRCCS Fondazione Don Carlo Gnocchi ONLUS
- IRCCS Mondino Foundation
- IRCCS San Raffaele Roma
- IRCCS San Camillo Hospital
- ICS Maugeri SB IRCCS Veruno
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Telerehabilitation Group (TG)
Control Group (CG)
The TG consisted of 30 sessions lasting approximately 45 minutes (3-5/week for 6-10 weeks) of motor, and cognitive rehabilitation exercises in non-immersive VR-based TR modality using the VRRS Tablet system (Khymeia Srl, Noventa Padovana, Italy).
The CG carried consisted of 30 sessions lasting approximately 45 minutes (3-5 days/week for, 6-10 weeks) of at-home conventional rehabilitation via structured self-administered exercises without the use of any technological devices.